We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

88 hedge funds and large institutions have $12.6M invested in Definium Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

879% more call options, than puts

Call options by funds: $9.78M | Put options by funds: $999K

13% more capital invested

Capital invested by funds: $11.1M → $12.6M (+$1.41M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.12% less ownership

Funds ownership: 13.48% → 10.36% (-3.1%)

15% less funds holding

Funds holding: 104 → 88 (-16)

27% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 22

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
88
Holders Change
-16
Holders Change %
-15.38%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
16
Reduced
22
Closed
19
Calls
$9.78M
Puts
$999K
Net Calls
+$8.78M
Net Calls Change
+$1.56M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$447K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$220K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$194K
4
Renaissance Technologies
Renaissance Technologies
New York
+$185K
5
State Street
State Street
Massachusetts
+$76.8K

Top Sellers

Rank Fund Capital Flow
1
MFG
Merit Financial Group
Georgia
-$1.19M
2
Millennium Management
Millennium Management
New York
-$549K
3
Goldman Sachs
Goldman Sachs
New York
-$236K
4
Citadel Advisors
Citadel Advisors
Florida
-$205K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
GFWA
76
Grey Fox Wealth Advisors
Delaware
$19 +$20 +6 New
SIS
77
Strategic Investment Solutions
Illinois
$19 +$20 +6 New
AF
78
Advisornet Financial
Minnesota
$10 – – –
HS
79
Horan Securities
United States
$6 -$110 -33 -94%
S
80
SignatureFD
Georgia
$6 – – –
HNB
81
Huntington National Bank
Ohio
$1 – – –
MFG
82
Merit Financial Group
Georgia
– -$1.19M -540,287 Closed
Millennium Management
83
Millennium Management
New York
– -$549K -249,450 Closed
VF
84
Virtu Financial
New York
– -$154K -70,157 Closed
CSS
85
Cubist Systematic Strategies
Connecticut
– -$136K -61,769 Closed
FC
86
Fore Capital
New York
– -$106K -47,999 Closed
OQS
87
Occudo Quantitative Strategies
Florida
– -$92.1K -41,864 Closed
AC
88
Aristides Capital
Kentucky
– -$82.8K -37,625 Closed
TSS
89
Two Sigma Securities
New York
– -$53K -24,099 Closed
ETC
90
Exchange Traded Concepts
Oklahoma
– -$32.9K -14,955 Closed
SSA
91
Schonfeld Strategic Advisors
New York
– -$22.9K -10,400 Closed
EGM
92
Engineers Gate Manager
New York
– -$22.2K -10,076 Closed
Simplex Trading
93
Simplex Trading
Illinois
– -$4.57K -1,374 Closed
Legal & General Group
94
Legal & General Group
United Kingdom
– -$2.25K -1,025 Closed
AWM
95
Accurate Wealth Management
Florida
– -$1.8K -649 Closed
MCC
96
Money Concepts Capital
Florida
– -$1.1K -500 Closed
Citigroup
97
Citigroup
New York
– -$79 -36 Closed
OAJ
98
Ogorek Anthony Joseph
New York
– +$53 +16 New
VF
99
VitalStone Financial
Texas
– +$1.16K +350 New
1 2 3
4

DFTX Hedge Fund Activity: Q1 2023 in Review

88 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q1 2023, worth a combined $12.6M — up 13% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of DFTX and 8 opened new positions — a net loss of 11 holders — while 22 trimmed existing stakes and 16 added.

The largest buyer was Two Sigma Investments, adding an estimated $447K. The largest seller was Merit Financial Group, exiting entirely with an estimated $1.19M sold.

  • 88 institutional investors held Definium Therapeutics (DFTX) as of Q1 2023, down from 104 in Q4 2022.
  • Funds reported $12.6M of Definium Therapeutics stock for Q1 2023, up 13% quarter-over-quarter.
  • 8 funds opened new Definium Therapeutics positions in Q1 2023 and 19 closed out, a net change of -11 holders.
  • The largest Definium Therapeutics buyer in Q1 2023 was Two Sigma Investments, an estimated $447K added.
  • The largest Definium Therapeutics seller in Q1 2023 was Merit Financial Group, an estimated $1.19M sold.

Based on aggregated 13F filings for Q1 2023.